BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue removal system.
Zacks Investment Research on MSN
BDX introduces BD Research Cloud 7.0 for advanced flow cytometry
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the global commercial launch of BD Research Cloud 7.0, marking another step forward in its AI-driven life sciences strategy ...
BD and Envetec prove medical plastic waste can be safely recycled into new products reducing landfill dependency ...
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
Franklin Lakes, New Jersey Tuesday, January 27, 2026, 10:00 Hrs [IST] ...
FRANKLIN LAKES, N.J., Oct. 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global leader in medical technology, introduces the BD Incada™ Connected Care Platform, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results